Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  January 3, 2024
Memoranda
Forecast for U.S. Federal and International Chemical Regulatory Policy 2024

Click here for a PDF brochure of the memorandum Bergeson & Campbell, P.C. (B&C®) and its global consulting affiliate The Acta Group (Acta®)...

  March 2, 2024
Global Regulatory Updates
Global Regulatory Update for March 2024

AUSTRALIA Final Guidance On Environmental Claims Includes Principles To Guide Business: On December 12, 2023, the Australian Competition and Consumer...

  May 22, 2023
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  January 30, 2024
Memoranda
EPA Holds Webinar on PFAS Reporting Rule Requirements

On January 25, 2024, the U.S. Environmental Protection Agency (EPA) held a webinar on EPA’s Toxic Substances Control Act (TSCA) Section 8(a)(7) rule...

  January 29, 2024
Memoranda
Senate Committee Holds Hearing on TSCA Implementation

The Senate Environment and Public Works Committee held a hearing on January 24, 2024, on “Oversight of Toxic Substances Control Act (TSCA)...

  January 12, 2024
Memoranda
EPA Issues Final SNUR to Prevent Inactive PFAS from Reentering Commerce

On January 11, 2024, the U.S. Environmental Protection Agency (EPA) issued a final significant new use rule (SNUR) to prevent companies from starting...

  December 14, 2023
REACHblog®
ECHA Calls for Evidence on Certain Chromium (VI) Substances

According to an item in the December 13, 2023, issue of the ECHA Weekly, the European Chemicals Agency (ECHA) is looking for information for a...

  November 22, 2023
Global Regulatory Updates
Global Regulatory Update for November 2023

AUSTRALIA AICIS Posts Video On Proposed Changes To AICIS Rules And Guidelines On Categorization, Reporting, And Recordkeeping: The Australian...

Seminars & Webinars

  December 18, 2023
Seminars & Webinars
FIFRA Hot Topics, March 12, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

Register now to join The Acta Group (Acta®) affiliate Bergeson & Campbell, P.C. (B&C®) for “FIFRA Hot Topics,” a complimentary webinar...

  December 18, 2023
Seminars & Webinars
Harmonizing TSCA Consent Orders with OSHA HCS 2012, May 14, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

B&C and Acta are pleased to present “Harmonizing TSCA Consent Orders with OSHA HCS 2012.” Registration is open now....

  December 18, 2023
Seminars & Webinars
PFAS — Determining PFAS Content in Your Organization and Expanding Data Collection Practice, July 23, 2024, 11:00 a.m. – 12:00 p.m. (EDT), via webinar

B&C and Acta are pleased to present “PFAS — Determining PFAS Content in Your Organization and Expanding Data Collection Practice.” More...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, seven Ph.D.’s. Government affairs and regulatory specialists including nine high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.